BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 3, 2006
View Archived Issues
SuperGen to acquire Montigen Pharmaceuticals
Read More
Pharmos completes phase I study for cannabinor
Read More
CytRx to transfer RNAi therapeutics to new subsidiary
Read More
Rigel receives milestone payment from Merck ubiquitin ligase collaboration
Read More
Curcumin plus phenethyl isothiocyanate active against prostate cancer in vivo
Read More
H5N1 Avian influenza virus vaccine effective in mice and chickens
Read More
Albany Molecular Research to acquire ComGenex
Read More
IGFR inhibition shows promise for malignant mesothelioma
Read More
New D3R antagonist prevents negative symptoms of schizophrenia
Read More
New agents for immunological disorders imparted in recent Taisho patent
Read More
Recent patents describe new therapeutic agents for anxiety, depression etc.
Read More
Novel agents imparted for the treatment of inflammatory disorders
Read More
Shionogi describes new antiobesity agents in patent literature
Read More
CombinatoRx and Fovea to develop novel ophthalmic therapeutics
Read More
New phase I/II study for ZIO-101 in advanced myeloma
Read More
Thiovir active against influenza A virus in preclinical studies
Read More
Ardana holds pre-IND meeting with FDA for testosterone cream
Read More
Pharmexa files first application for phase III PrimoVax trial
Read More
Nastech and P&G collaborate on nasal PTH1-34
Read More
TP-508 promotes cartilage repair via activation of ERK1/2 MAPK
Read More
New respiratory agents highlighted in patent literature
Read More
Symphogen and Biovitrum to codevelop and commercialize SYM-001
Read More
Zalypsis to enter clinical testing in U.S.
Read More
LY-2275796 enters clinical trials in cancer patients
Read More
CONRAD and Cellegy sign agreement for microbicide R&D
Read More
Clarinex-D 12 Hour approved for seasonal allergic rhinitis
Read More
EMEA accepts for review Genasense MAA in melanoma
Read More
